---
title: "How countries adapt the WHO Model List of Essential Medicines: alignment versus expansion"
id: "medrxiv-22-alignment-and-expansion-in-national-adaptation-of-the-who-model-list-of"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-22-alignment-and-expansion-in-national-adaptation-of-the-who-model-list-of"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# How countries adapt the WHO Model List of Essential Medicines: alignment versus expansion
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-22-alignment-and-expansion-in-national-adaptation-of-the-who-model-list-of
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors compared national essential medicines lists (**NEMLs**) from 137 countries directly with the **WHO EML** to measure two separate adaptation dimensions. - They defined an **Alignment Ratio** (proportion of WHO-recommended medicines present on each NEML) and an **Expansion Ratio** (proportion of NEML medicines not on the WHO list). - The team categorized countries into four adaptation modes using combinations of alignment and expansion scores; all four modes were represented across the sample. - Distribution by mode: 50 countries were classified as restrictive/constrained adoption (low alignment, low expansion); 35 as normative dependence (high alignment, low expansion); 16 as autonomous divergence (low alignment, high expansion); and 36 as capacity-driven expansion (high alignment, high expansion). - Multivariable beta regression examined country-level predictors of the two ratios. - Higher under-five mortality correlated with lower alignment (β = −0.294; 95% CI: −0.497 to −0.091) and with lower expansion (β = −0.481; 95% CI: −0.697 to −0.264). - Greater globalization index scores and more recent NEMLs were associated with higher alignment but did not predict expansion. - The authors concluded that many countries supplement the **WHO EML** rather than substitute it, combining strong alignment with substantial national additions. - The article is a medRxiv preprint; the full dataset is available from the authors on reasonable request.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=e6vHeBlOrMbguHkMOC2zo1nD7Yso0fG_duqgzjFt1y4-1795233489.044066-1.2.1.1-5jCQRnCX7ZaBW1mcdbvaHLOu63jpbTMCiMN1FrvXHY0exfApBlT9LXUxcypNj46b) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Alignment and expansion in national adaptation of the WHO Model List of Essential Medicines: a cross-national analysis [ View ORCID Profile](http://orcid.org/0009-0000-8993-494X)Yukari Kohno, [ View ORCID Profile](http://orcid.org/0000-0001-9544-1447)Janne Estill, [ View ORCID Profile](http://orcid.org/0000-0001-6680-6507)Lorenzo Moja, [ View ORCID Profile](http://orcid.org/0000-0001-8191-2789)Olivia Keiser doi: https://doi.org/10.64898/2026.11.19.26368472 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Yukari Kohno 1 Global Studies Institute, University of Geneva, Geneva, Switzerland; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yukari%2BKohno%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kohno%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYukari%2BKohno%2B) * [ORCID record for Yukari Kohno](http://orcid.org/0009-0000-8993-494X "Open in new tab") * For correspondence: jpyukari@gmail.com Janne Estill 2 Institute of Global Health, University of Geneva, Geneva, Switzerland; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Janne%2BEstill%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Estill%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJanne%2BEstill%2B) * [ORCID record for Janne Estill](http://orcid.org/0000-0001-9544-1447 "Open in new tab") Lorenzo Moja 3 Department of Medicines and Health Products Policies and Standards, World Health Organization; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lorenzo%2BMoja%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Moja%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALorenzo%2BMoja%2B) * [ORCID record for Lorenzo Moja](http://orcid.org/0000-0001-6680-6507 "Open in new tab") Olivia Keiser 4 University of Geneva Faculty of Medicine: Universite de Geneve Faculte de Medecine * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Olivia%2BKeiser%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Keiser%20O&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AOlivia%2BKeiser%2B) * [ORCID record for Olivia Keiser](http://orcid.org/0000-0001-8191-2789 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1349907/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1349907/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1349907/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1349907/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1349907/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: The WHO Model List of Essential Medicines (EML) provides a common global reference for national medicines selection. National adaptation frequently involves both the adoption of WHO-recommended medicines and the addition of medicines beyond WHO EML, which have not been distinguished in comparative analyses. This study quantifies how countries adapt the WHO EML by distinguishing alignment from expansion, exploring country-level characteristics potentially associated with these dimensions. Methods: We compared national essential medicines lists (NEMLs) from 137 countries with the WHO EML. We constructed two independent measures: the Alignment Ratio, representing the proportion of WHO-recommended medicines included in each NEML, and the Expansion Ratio, representing the proportion of NEML medicines not included in the WHO EML. Countries were also classified into four adaptation modes based on combinations of alignment and expansion. Associations with country-level characteristics were examined using multivariable beta regression. Results: Countries displayed substantial heterogeneity in adaptation patterns, with representation across all four adaptation modes defined by alignment with and expansion beyond the WHO EML. Fifty countries were categorized as restrictive/constrained adoption (low alignment, low expansion), thirty-five countries as normative dependence (high alignment, low expansion), sixteen countries as autonomous divergence (low alignment, high expansion) and thirty-six countries as capacity-driven expansion (high alignment, high expansion). Higher under-five mortality was associated with lower alignment (β = −0.294; 95% CI: −0.497 to −0.091) and lower expansion (β = −0.481; 95% CI: −0.697 to −0.264). Higher globalization index scores and more recent NEMLs were associated with higher alignment, but not expansion. Conclusion: While some countries closely followed the WHO EML with limited additions, a substantial proportion combined high alignment with extensive expansion beyond the WHO benchmark, suggesting that national adaptation often involves supplementation rather than substitution of WHO recommendations. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.18.26368445v1 "Predicting county-level opioid overdose mortality in Ohio through multimodal data: A spatiotemporal study using toxicology and EMS indicators, 2020-2024") Posted November 20, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/20/2026.11.19.26368472.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.19.26368472v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/20/2026.11.19.26368472.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Alignment and expansion in national adaptation of the WHO Model List of Essential Medicines: a cross-national analysis Yukari Kohno, Janne Estill, Lorenzo Moja, Olivia Keiser medRxiv 2026.11.19.26368472; doi: https://doi.org/10.64898/2026.11.19.26368472 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.19.26368472v1%26text%3DAlignment%2520and%2520expansion%2520in%2520national%2520adaptation%2520of%2520the%2520WHO%2520Model%2520List%2520of%2520Essential%2520Medicines%253A%2520a%2520cross-national%2520analysis "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.19.26368472v1%26t%3DAlignment%2520and%2520expansion%2520in%2520national%2520adaptation%2520of%2520the%2520WHO%2520Model%2520List%2520of%2520Essential%2520Medicines%253A%2520a%2520cross-national%2520analysis "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.19.26368472v1%26title%3DAlignment%2520and%2520expansion%2520in%2520national%2520adaptation%2520of%2520the%2520WHO%2520Model%2520List%2520of%2520Essential%2520Medicines%253A%2520a%2520cross-national%2520analysis%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.19.26368472v1%26title%3DAlignment%2520and%2520expansion%2520in%2520national%2520adaptation%2520of%2520the%2520WHO%2520Model%2520List%2520of%2520Essential%2520Medicines%253A%2520a%2520cross-national%2520analysis "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.19.26368472) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (928) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5059) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (432) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1703) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16352) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (37) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1249) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7333) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (761) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1101) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5350) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1480) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1847) * [Hematology](https://www.medrxiv.org/collection/hematology) (604) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1389) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16537) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1210) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (757) * [Neurology](https://www.medrxiv.org/collection/neurology) (7664) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1144) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1308) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1046) * [Oncology](https://www.medrxiv.org/collection/oncology) (3769) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1105) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (414) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (474) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (508) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (727) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1877) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (759) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (793) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6186) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10051) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2562) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1540) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1280) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (666) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (814) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (601) * [Surgery](https://www.medrxiv.org/collection/surgery) (809) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (321) * [Urology](https://www.medrxiv.org/collection/urology) (309) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the c
## Related Clinical Research

- [Allergens in glucose monitoring systems identified by validated GC-MS; evidence of a 'sponge effec](https://medichelpline.com/clinical-feed/pubmed-42887950.md) (DOI: 10.1016/j.aca.2026.346179)
- [Bisphenol A in follicular fluid and associations with oocyte maturation and embryo arrest in IVF](https://medichelpline.com/clinical-feed/pubmed-43062947.md) (DOI: 10.1080/09513590.2026.2766634)
- [Big Pharma: AI halves early drug-discovery timelines; companies avoid Xinjiang trial sites](https://medichelpline.com/clinical-feed/stat-news-0-stat-pharmalittle-we-re-reading-about-sanofi-eyeing-insmed-ai-speeding-drug.md)
- [ITE-Transformer: Pretrained model for individualized treatment effects from EHRs](https://medichelpline.com/clinical-feed/medrxiv-17-the-ite-transformer-a-pre-trained-foundation-model-for-predicting.md)
- [Hims and Noom bring experimental peptides to mainstream telehealth](https://medichelpline.com/clinical-feed/stat-news-1-stat-peptide-market-poised-to-explode-with-new-hims-and-noom-launches.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.